| Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis RM Smith, RB Jones, U Specks, S Bond, M Nodale, R Aljayyousi, ... Annals of the rheumatic diseases 79 (9), 1243-1249, 2020 | 150 | 2020 |
| The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink JG Royle, PC Lanyon, MJ Grainge, A Abhishek, FA Pearce Clinical rheumatology 37, 2103-2111, 2018 | 93 | 2018 |
| Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population FA Pearce, PC Lanyon, MJ Grainge, R Shaunak, A Mahr, RB Hubbard, ... Rheumatology 55 (9), 1656-1663, 2016 | 84 | 2016 |
| Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody–associated vasculitis FA Pearce, A Craven, PA Merkel, RA Luqmani, RA Watts Rheumatology 56 (11), 1962-1969, 2017 | 77 | 2017 |
| Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic E Peach, M Rutter, P Lanyon, MJ Grainge, R Hubbard, J Aston, M Bythell, ... Rheumatology 60 (4), 1902-1909, 2021 | 72 | 2021 |
| Role of the CD40 Locus in Graves’ Disease FA Houston Thyroid, 2004 | 70 | 2004 |
| Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines J Tieu, R Smith, N Basu, P Brogan, D D’Cruz, N Dhaun, O Flossmann, ... Rheumatology 59 (4), e24-e32, 2020 | 63 | 2020 |
| The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink FA Pearce, MJ Grainge, PC Lanyon, RA Watts, RB Hubbard Rheumatology 56 (4), 589-596, 2017 | 57 | 2017 |
| Worldwide relative smoking prevalence among people living with and without HIV PI Johnston, SW Wright, M Orr, FA Pearce, JW Stevens, RB Hubbard, ... Aids 35 (6), 957-970, 2021 | 48 | 2021 |
| Interstitial lung disease following certolizumab pegol F Pearce, SR Johnson, P Courtney Rheumatology 51 (3), 578-580, 2012 | 45 | 2012 |
| A systematic review and meta-analysis of the incidence rate of Takayasu arteritis M Rutter, J Bowley, PC Lanyon, MJ Grainge, FA Pearce Rheumatology 60 (11), 4982-4990, 2021 | 41 | 2021 |
| Does smoking reduce the progression of osteoarthritis? Meta‐analysis of observational studies F Pearce, M Hui, C Ding, M Doherty, W Zhang Arthritis care & research 65 (7), 1026-1033, 2013 | 34 | 2013 |
| Lupus nephritis: a 15‐year multi‐centre experience in the UK M Hui, R Garner, F Rees, R Bavakunji, P Daniel, S Varughese, A Srikanth, ... Lupus 22 (3), 328-332, 2013 | 33 | 2013 |
| Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis J La-Crette, J Royle, PC Lanyon, A Ferraro, A Butler, FA Pearce Clinical rheumatology 37, 1085-1090, 2018 | 29 | 2018 |
| COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis R Cordtz, S Kristensen, R Westermann, K Duch, F Pearce, J Lindhardsen, ... Rheumatology 62 (1), 77-88, 2023 | 27 | 2023 |
| COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER project M Rutter, PC Lanyon, MJ Grainge, R Hubbard, E Peach, M Bythell, ... Rheumatology 61 (8), 3161-3171, 2022 | 23 | 2022 |
| Novel insights into the aetiology of granulomatosis with polyangiitis—a case–control study using the Clinical Practice Research Datalink FA Pearce, PC Lanyon, RA Watts, MJ Grainge, A Abhishek, RB Hubbard Rheumatology 57 (6), 1002-1010, 2018 | 23 | 2018 |
| Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide A Abhishek, R Yazdani, F Pearce, M Regan, K Lim, R Hubbard, P Lanyon Clinical rheumatology 30, 1099-1104, 2011 | 21 | 2011 |
| Can granulomatosis with polyangiitis be diagnosed earlier in primary care? A case–control study FA Pearce, RB Hubbard, MJ Grainge, RA Watts, A Abhishek, PC Lanyon QJM: An International Journal of Medicine 111 (1), 39-45, 2018 | 19 | 2018 |
| The global burden of anti-neutrophil cytoplasmic antibody vasculitis: High but unquantified RA Watts, J Robson, F Pearce Rheumatology 56 (9), 1439-1440, 2017 | 13 | 2017 |
